colorectal cancer, colorectal polyp
Conditions
Interventions
Polyethylene glycol lavage solution plus contrast medium (PEG-C) preparation before CT colonography
Polyethylene glycol lavage solution plus contrast medium and Mosapride Citrate Hydrate (PEG-CM) prep
Sponsors
Kamigoto Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who are eligible for optical colonoscopy. 2) Aged 20 years or older. 3) Major functions of organs of the subjects are in a good condition. 4) Signed informed consent forms are obtained by the patients.
Exclusion criteria
Exclusion criteria: 1) Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit. 2) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon. 3) Evidence of an increased risk in carrying out bowel preparation or CTC exams. 4) Possibility of pregnancy. 5) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial. 6) Iodine hypersensitivity. 7) Severe thyroid disease. 8) Claustrophobia. 9) Severe deafness. 10) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PEG-C versus PEG-C + Mosapride Citrate Hydrate for bowel preparation before CT colonography to be asscessed by the amount of residual fluid. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparative adherence of patients to PEG-C preparation and PEG-C + Mosapride Citrate Hydrate preparation. Frequency and nature of any adverse events. | — |
Countries
Japan
Contacts
Public ContactTetsuro Honda
Kamigoto Hospital Kamigoto Hospital
Outcome results
None listed